Senior HRSA Official Pedley to Deliver ASHP’s Prestigious William A. Zellmer Lecture Next Week

Rear Admiral Krista Pedley saluting
Rear Adm. Krista Pedley, director of HRSA's Office of Special Health Initiatives, addressed the 340B patient definition at a conference Tuesday.

U.S. Public Health Service Rear Adm. Krista Pedley, a top official at the Health Resources and Services Administration (HRSA) and former longtime head of the 340B drug pricing program, has been selected by the American Society of Health-System Pharmacists (ASHP)

Read More »

Judge Continues Stay in 340B Dispute Resolution Lawsuit

screenshot of HRSA 340B, Administrative dispute resolution web page
A federal district judge continued the stay in community health centers’ lawsuit over the 340B administrative dispute resolution process.

A federal district judge on Wednesday continued the stay in community health centers’ lawsuit against federal health officials over the administrative dispute resolution process for the 340B program after accepting the explanation for a missed deadline to file a report

Read More »

White House Seeks $27 Billion for COVID-19 and Monkeypox Response

bare arms presenting Monkeypox Mpox rash blisters
The Biden administration is requesting $27 billion to combat monkeypox and COVID-19, but Senate Republicans are signaling skepticism and resistance.

The Biden administration is requesting $27 billion to combat monkeypox and COVID-19 as part of a stopgap spending bill to fund the government past the end of fiscal year 2022, which ends Sept. 30. Senate Republicans are signaling skepticism and

Read More »

Federal Judge Asks About Overdue Status Report in 340B Dispute Resolution Case

Florence Pan headshot
U.S. District Judge Florence Pan signaled her displeasure with NACHC and the federal government for missing a Sept. 3 deadline for a legal filing.

A federal district judge in Washington, D.C., yesterday ordered community health centers to answer why she should not dismiss their lawsuit against federal health officials over the administrative dispute resolution process for the 340B program.

Judge Florence Pan of U.S.

Read More »

MedPAC May Back a Cut in Part B Drug Payments, This Time Not for 340B Hospitals Only

chart indicating average sale price of drugs MedPAC
MedPAC is considering whether to recommend reducing the 6% add-on to Part B drug reimbursement to decrease the incentives for providers to use higher-priced drugs.

Congressional Medicare advisers are weighing whether to recommend converting the 6% add-on to Part B drug reimbursement to a fixed fee capped at $175 for drugs that cost $15,000 or more, phased in starting with drugs costing above $700.

Medicare

Read More »

Federal Health Officials with Significant 340B History Play Major Roles in CDC Revamp

Mary Wakefield, James Macrae headshots
Ex-HRSA Administrator Mary Wakefield and current HRSA Associate Administrator are playing pivotal roles in the U.S. Centers for Disease Control and Prevention overhaul.

Two federal health officials with long track records managing key aspects of the 340B program are playing pivotal roles in a major overhaul of the U.S. Centers for Disease Control and Prevention.

CDC Director Rochelle Walensky last month named Mary

Read More »

News Alert

Becerra Says Legislation Is Needed to Strengthen HHS Authority to Address 340B Contract Pharmacy Pricing Denials

Xavier Becerra speaking to the press
Congress needs to give HHS more more regulatory power and money if its wants the department to do more about drug companies that curtail the use of 340B drugs in contract pharmacies, HHS Secretary Xavier Becerra told House members in a Sept. 1 letter.

U.S. Health and Human Services Secretary Xavier Becerra told members of Congress on Thursday that his department is doing all it can with the tools it has to address drug manufacturers’ denials of 340B pricing involving contract pharmacies.

If lawmakers

Read More »

340B Report Exclusive: CMS May Owe 340B Hospitals More Money Than Anticipated

health care worker inserts IV into patient's arm
There have been various estimates of how much it will cost the U.S. government to remedy unlawful Medicare Part B drug payment cuts for 340B hospitals.

The potential cost to the U.S. government next year of remedying unlawful Medicare Part B drug payment cuts for 340B hospitals could be higher than federal Medicare officials think.

The U.S. Centers for Medicare & Medicaid Services in mid-July put

Read More »

340B Stakeholders Seek Clarity on HRSA Flexibilities as COVID-19 Public Health Emergency Winds Down

screenshot of HRSA COVID-19 resources web page
340B covered entities are wondering if 340B program COVID-19 flexibilities might become permanent 340B program features.

The U.S. Center for Medicare & Medicaid Services encouraged health care providers on its blog last month “to prepare for the end” of its COVID-19 waivers and flexibilities “as soon as possible and to begin moving forward to reestablishing previous

Read More »

GOP House Leaders Want Answers from Becerra on Implementation and Impact of Medicare Drug Price Negotiation

Screenshot of Reps. Kevin Brady, Cathy McMorris Rodgers, and Kevin McCarthy on C-SPAN
Ranking Republicans Kevin Brady (left) and Cathy McMorris Rodgers (center) of House Ways & Means and Energy & Commerce committees sent a letter to HHS foreshadowing intensified oversight if Republicans win back control of the House in November.

Top U.S. House Republicans sent U.S. Health and Human Services Secretary Xavier Becerra a letter on Monday asking 18 detailed questions about implementation and oversight of the Inflation Reduction Act’s (IRA) Medicare drug price negotiation provisions. Their interrogation foreshadows intensified

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report